Related Experiment Video

Updated: Jun 12, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Clinical and angiographic predictors of ST-segment recovery after primary percutaneous coronary intervention

Niels J W Verouden1, Joost D E Haeck, Wichert J Kuijt

  • 1Department of Cardiology, University of Amsterdam, Amsterdam, The Netherlands.

The American Journal of Cardiology
|June 12, 2010
PubMed

Insights

Incomplete ST-segment recovery after primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) is common. Key predictors include older age, diabetes, and left anterior descending artery STEMI, indicating a need for early risk stratification and potential adjunctive therapies.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Electrocardiography

Background:

  • Incomplete ST-segment recovery post-primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) impacts patient outcomes.
  • Early identification of STEMI patients with incomplete ST-segment recovery is crucial for guiding treatment strategies and potentially improving myocardial salvage.

Purpose of the Study:

  • To identify key determinants of incomplete ST-segment recovery following primary PCI in STEMI patients.
  • To evaluate the prognostic significance of incomplete ST-segment recovery on long-term mortality.

Main Methods:

  • Analysis of 12-lead electrocardiograms from 2,124 STEMI patients undergoing primary PCI between 2000 and 2007.
  • ST-segment recovery was quantified as the percent change in cumulative ST-segment deviation, with <50% defined as incomplete.
  • Multivariable logistic regression and Cox proportional hazards models were employed to identify predictors and assess mortality risk.

Main Results:

  • Nearly half (49%) of STEMI patients experienced incomplete ST-segment recovery.
  • Independent predictors of incomplete recovery included age >60 years, diabetes mellitus, left anterior descending coronary artery-related STEMI, and multivessel disease.
  • Current smoking and preprocedural Thrombolysis In Myocardial Infarction (TIMI) grade <3 flow were inversely associated with ST-segment recovery.
  • Incomplete ST-segment recovery strongly predicted long-term mortality (HR 2.07).

Conclusions:

  • Incomplete ST-segment recovery after primary PCI for STEMI is associated with specific clinical factors: older age, diabetes, LAD-STEMI, multivessel disease, and higher pre-PCI TIMI flow.
  • These findings highlight the importance of recognizing patients at risk for incomplete recovery, who may benefit from intensified or adjunctive therapies to improve outcomes.

More Related Videos

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...